Royalty Pharma Total Non-Operating Income/Expense 2019-2025 | RPRX
Royalty Pharma total non-operating income/expense for the twelve months ending March 31, 2025 was $-0.132B, a 153.32% decline year-over-year.
- Royalty Pharma annual total non-operating income/expense for 2024 was $0.038B, a 81.55% decline from 2023.
- Royalty Pharma annual total non-operating income/expense for 2023 was $0.208B, a 370.05% decline from 2022.
- Royalty Pharma annual total non-operating income/expense for 2022 was $-0.077B, a 59.37% decline from 2021.